Rectal cancer neoadjuvant therapy

Augustin-Marian Marincas - Referințe bibliografice Google Academic

Student Project abstract The investigation of platinum-based drug effect on tumor stem cells responsible for tumor generation and propagation is a rectal cancer neoadjuvant therapy and expanding field, and in rectal cancer neoadjuvant therapy colorectal cancer casuistry they are many features uncovered.

paraziti antimilitie papiloma bucal benigno

Studies concerning the action of platinum compounds against immune mechanisms focusing activated lymphocytes involved could bring novelties in the field of cancer cell biochemistry and function. Our aim is to perform a multidisciplinary and translational study that impact patient care in colorectal carcinoma.

Multidisciplinary Treatment of Colorectal Cancer Staging – Treatment – Pathology – Palliation

The project objective is to evaluate the platinum-containing drugs effect on stem cells in colorectal carcinoma, this population being responsible for the resistance against chemotherapy treatment.

It is feasible to assess the platinum-treated stem cells, with accent on apoptosis, multidrug resistance, metabolism and cell signaling.

  • The result is a highly engaging and authoritative tome in the grand tradition of Philip Gordon and Santhat Nivatvongs.
  • Colorectal cancer neoadjuvant therapy Neoadjuvant and Adjuvant Therapy in Metastatic Colorectal Cancer human papillomavirus vaccine problems Provides state of the art information on surgery, oncology, imaging, staging, pathology, and palliation Explains how to organize the multidisciplinary team Addresses key controversies Aids understanding and communication among team members About this book This book is intended as the equivalent of the Swiss Army knife for all members of colorectal cancer CRC multidisciplinary teams and those training in the fields of CRC management.
  • Low ante-rior resection of the rectum with total mesorectal excision was performed in all the patients.
  • Parazitii unde ai fost ce ai facut
  • Simptome parazitare în tratamentul corpului uman
  • Rectal cancer neoadjuvant.
  • Paraziti intestinali giardia
  • Scripcariu Universitatea de Medicină şi Farmacie ,Gr.

The project intends to investigate the percent of stem cells having genetic mutations, and the effect of platinum-based compounds on cell populations which display chemoresistance versus targeted anti-EGFR therapy. We propose also to examine the lymphocyte populations implicated in antitumoral immune response, in order to establish the magnitude of immunomodulation following the platinum compounds action.

Neoadjuvant/Adjuvant Approaches in Colorectal Cancer

General objectives of the project A multidisciplinary assessment is proposed, which is capable to merge the scientific achievements of basic and clinical studies and to improve the results quality. Our aim is to perform a basic and translational study that impact patient care in colorectal carcinoma.

Romania Cancer Oranisations and Resources | CancerIndex

The project main objective is to evaluate the platinum-containing drugs impact on stem cells, these population being responsible for the tumoral dissemination and resistance against chemotherapy treatment. The clue of the treatment resides in the proportion of stem cells inhibited by the drug in the whole tumoral population, and the project proposes to identify and characterize the changes which occur in colon carcinoma stem cells during platinum chemotherapy.

It is feasible to compare using functional genomic methods the platinum-treated stem and non-stem in the tumoral mass with accent on cells apoptosis, multidrug resistance, metabolism and cell signaling. The project intends to investigate the percent of stem cells having genetic mutations, and the effect of platinum-based compounds on EGFR-chemoresistant cell populations.

Case report Conf. Grigorescu, Şef lucrări dr. Some rectal cancer neoadjuvant these patients address the doctors in locally advanced stages, sometimes without the possibility to perform resection. The challenge of the multimodal oncologic treatment of those patients is to obtain conversion towards resection, and rectal cancer neoadjuvant the decrease of the local recurrence, thus ensuring the increase of the long-term survival, targets which are often difficult to obtain.

One of our objectives is to scan the lymphocyte populations implicated in antitumoral immune response, emphasizing the Rectal cancer neoadjuvant therapy positive T lymphocytes and the natural killer cells, in order to establish the magnitude of the changes in human body immune response potential following the platinum compounds action. Lymphocytes from both peripheral blood and lymph nodes will be evaluated. The proposed objectives were completed, bringing new, significant results in biochemistry of the platinum compounds, the most important metal involved in chemotherapy, but also the platinum-group metals PGMother metal complexes and their ligands showing therapeutic potential.

We revealed multiple aspects of platinum-based chemotherapy, which join the outcomes of basic biochemical, genomic, proteomic and immune methods in order to improve the therapeutically benefits.

Gordon and Nivatvongs' Principles and Practice of Surgery for the Colon, Rectum, and Anus

After accomplishing all phases of the project, the final results of the project are: Scientific publications which acknowledges the project, indexed on Web of Science Thomson Reuters ISI: 1. IF 0,; influency score 0, Synthesis of structural analogues of hexadecylphosphocholine and their antineoplastic, antimicrobial and amoebicidal activity.

European Journal of Medicinal Chemistry, Imunomodulatory potential of palladium II complexes with 1E,6E -1,7-bis 3,4-dimethoxyphenyl hepta-1,6-diene-3,5-dione. Notulae Botanicae Horti Agrobotanici,43 2 : Platinum derivatives: generic brands vs. Journal: Inorganic Chemistry Communications Elsevier, — Papers in journals indexed by international databases: Clujul Medical,88 3 : Ferdinand Devinsky from the Comenius University in Bratislava. Gregory S. Virag, M.

Which neoadjuvant treatment in rectal cancer? Neoadjuvant treatment's tumor response in rectal cancer - Jurnalul de - primariabeuca. Ocazional, intenia curativ poate fi deliberat compromis, fie datorit comorbiditilor asociate, prea severe pentru a permite o rectal cancer neoadjuvant therapy standard n deplin siguran, fie datorit refuzului pacientului de a accepta protocolul standard cu intenie curativ.

Perde-Schrepler, C. Tatomir, H. Decean, E.

îndepărtarea condilomului și consecințe necroză de helminti

Fischer-Fodor: UVB-activated signaling pathways and their modulation with Vitis vinifera seeds extract in human skin cells, Abstract Book, pages Virag, E. Improved oxygen-carrying blood substitutes in vitro effect on hematopoietic and endothelial cells.

Poster presentation.

  1. Pastile pentru tratamentul viermilor și viermilor
  2. Dna papillomavirus positivo
  3. "Chirurgia (Bucharest, Romania : )"[Journal] - PubMed Result, Colorectal cancer neoadjuvant therapy
  4. Negii au plecat de la sine
  5. [Strategy and Tactic in the Treatment of Local Advanced Rectal Cancer] - PubMed
  6. Colorectal cancer guidelines esmo Colorectal cancer esmo guideline

Virag, O. Balacescu, E.

paraziți de coevoluție și exemple de gazdă din ce negi genitale au apărut

Fischer-Fodor, M. Perde Schrepler, C.

Colorectal cancer neoadjuvant therapy

Tatomir, L. Balacescu, I. Biochemical aspects of apoptosis and immunomodulation as a consequence of the treatment with platinum complexes and other metal-based compounds with antitumor therapeutic potential Through two main activities: 6.

Evaluation of the molecules implicated in apoptotic signaling pathways in colorectal cells treated with metal complexes 6.

Neoadjuvant treatment's tumor response in rectal cancer - Jurnalul de - power-tuning.ro

Assessment of the metal compounds effect on lymphocyte subsets and cellular adhesion molecules The final phase of the project, PHASE VI December 10th December 31st was implemented by completing the following objective: 6. Evaluation of the molecules implicated in apoptotic signaling pathways in colorectal rectal cancer neoadjuvant therapy treated with metal complexes In order to identify new biomarkers connected to the apoptotic processes induced by metal compounds, the biologic effect of a new class of dysprosium complexes was studied; the antiproliferative effect of the Dy compounds was compared with that of standard platinum-based drugs.

The complex and its ligand toxicity were and we proved the decisive role of the central metal in the compounds biologic activity and in early apoptosis triggering. The treated tumor cell populations were exposed to a uniform magnetic filed, with an intensity which does not affected the cells viability, and we observed that unlike to the ligand or the platinum drugs, the magnetic field applied concomittant with in Dy III Na ampy 4]n treatment induced a stronger growth inhibitory effect on tumor populations.

The cancer cells drug resistance was impeded by the simultaneous application of the Dy complex and the magnetic field; this phenomenon was monitored through the evaluation of the MDR-1 biomarker of drug efflux in the cell, and a statistic significance was proved.

Provides state of the art information on surgery, oncology, imaging, staging, pathology, and palliation Explains how to organize the multidisciplinary team Addresses key controversies Aids understanding and communication among team members About this book This book is intended as the equivalent of the Swiss Army knife for all members of colorectal cancer CRC multidisciplinary teams and those training in the fields of CRC management.

The results of the research were published in the manuscript entitled: Multifunctional applications of a dysprosium-based metal—organic chain with single-ion rectal cancer neoadjuvant therapy behavior, Belén Fernández, Itziar Oyarzabal, Eva Fischer-Fodor, Sergiu Macavei, Ignacio Sánchez, José M. CrystEngComm,18, Under the frame of the 6. The compounds were synthesized and fully characterized by the team of Prof.

  • Scripcariu Universitatea de Medicină şi Farmacie ,Gr.
  • Neoadjuvant treatment's tumor response in rectal cancer - Jurnalul de - primariabeuca.
  • Some of these patients address the doctors in locally advanced stages, sometimes without the possibility to perform resection.
  • Zentel sirop oxiuri
  • Oxiuros identificacion perianal
  • Colorectal cancer neoadjuvant therapy - Papilloma genitale
  • Hpv laryngeal papillomatosis
  • Neoadjuvant treatment's tumor response in rectal cancer - Jurnalul de

Smith from the University of Cape Town, and published in J. Chem, The complexes were tested in vitro in order to elucidate their biologic activity against human colon cells in vitro.

Clinical Decision Making in Colorectal Surgery: Scott R. Steele · | Books Express

The inhibitory effect against the tumor cell populations was tested by MTT method and the degree of the toxicity was quantified using the IC50 half inhibitory concentration parameter, which revealed a superior toxicity against the invasive, mutant colon cancer cells. The compounds potential to induce the programmed cell death was evaluated through the identification by Annexin V binding of phosphatidyl-serine translocated to the cell outer membrane during apoptosis.

rectal cancer lymph node spread cancer bolsa peritoneal

In parallel, the number of necrotic cells was evaluated. This data are well correlated with the iron cellular uptake, measured with atomic absorption spectrometry.

[Strategy and Tactic in the Treatment of Local Advanced Rectal Cancer]

A manuscript was elaborated jointly with the research partners from South Africa. Assessment of the metal papillomavirus nonavalent vaccine effect on lymphocyte subsets and cellular adhesion molecules The activity implied to achieve the phase VI objective was the study of two complexes of the Platinum Group Metals PGMsteric isomers, having as central metal Pd II and the ligand 1e,6e -1,7-bis 4-dimethylamino phenyl hepta-1,6-diene-3,5 dione, in two different conformations.

Their antiproliferative effect was tested with colorimetric viability methods; the ligand was inactive, while the two complexes half inhibitory concentrations were significant lower was of ligand, proving a structure-activity relationship. More, the dose-response correlation was found in both complexes; the cis conformer A being more active against colon tumor cells. The compounds inclusion inside the tumor cells was evaluated based on their autofluorescence; a higher accumulation was observed in k-ras mutant DLD-1 cells.

Mai multe despre acest subiect